Wildfor
Google’s Pixel Watch 5 is promising — but it isn’t finished
Google's Pixel Watch 5 arrives with minimal hardware changes — slightly improved chips and battery, plus a new finish — while its most compelling health features, including blood pressure monitoring and insulin resistance tracking, remain unavailable at launch, making it a difficult device to fully evaluate right now.
The Pixel Watch 5 is shaping up to be one of Google's more challenging wearable releases to assess. On the hardware side, almost nothing has changed: the watch retains the same sizes as its predecessor, with only modest bumps to the processor and battery life, alongside a new pyrite satin color option. It's a notably incremental physical upgrade.
The real selling points are software-driven health features — specifically blood pressure monitoring and insulin resistance trend tracking — that tie into Google's revamped Health platform and AI coaching tools introduced alongside the Fitbit Air earlier this year. The catch is that none of these flagship features are actually available on the watch yet, leaving reviewers and early buyers unable to assess what may ultimately define the device's value proposition.
This raises a broader question about the growing trend of shipping hardware ahead of the software experiences meant to justify it, putting consumers in the position of buying promises rather than proven capabilities.
Google's Pixel Watch 5 has landed in reviewers' hands, and the verdict so far is more complicated than a simple thumbs up or down. From a pure hardware standpoint, the watch is nearly identical to its predecessor. Dimensions are unchanged, the processor and battery have received only minor improvements, and the sole cosmetic addition is a new pyrite satin case finish. For anyone expecting a dramatic leap forward in the physical product, the Watch 5 offers little excitement.
The real ambition behind this year's release is rooted in software and health technology. Google has been building out an overhauled Health ecosystem, anchored by an AI-powered coaching layer introduced with the Fitbit Air earlier in 2025. The Pixel Watch 5 was positioned as a key part of that platform, bringing features like blood pressure monitoring and insulin resistance trend analysis — capabilities that could genuinely differentiate it in a competitive smartwatch market dominated by Apple and Samsung.
The fundamental problem is that these headline features are not yet functional on the device. Reviewers cannot test the tools that are supposed to make the Watch 5 worth buying, which puts the entire review process in an awkward holding pattern. Evaluating the watch on its current capabilities means judging it largely on hardware that hasn't meaningfully evolved, while the features that matter most exist only as future promises.
Why it matters: This situation reflects a growing and somewhat troubling pattern across the consumer tech industry — shipping hardware with the expectation that software updates will eventually deliver the experience that was marketed at launch. Buyers who invest in the Pixel Watch 5 today are effectively betting that Google will follow through on its health feature roadmap on a reasonable timeline. That's a real risk, particularly given that health monitoring tools often face regulatory and technical hurdles that can delay or alter their final form.
For now, the Pixel Watch 5 sits in an uncertain middle ground: promising enough in concept to generate interest, but incomplete enough in execution to make recommending it straightforwardly difficult. Potential buyers may be better served waiting until the promised features actually arrive before committing.